Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

Karp JF, Whyte EM, Lenze EJ, Dew MA, Begley A, Miller MD, Reynolds CF 3rd.

J Clin Psychiatry. 2008 Mar;69(3):457-63.

2.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
4.

Escitalopram: a review of its use in the management of major depressive disorder in adults.

Garnock-Jones KP, McCormack PL.

CNS Drugs. 2010 Sep;24(9):769-96. doi: 10.2165/11204760-000000000-00000. Review.

PMID:
20806989
5.

Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.

Hirschfeld RM, Vornik LA.

J Clin Psychiatry. 2004;65 Suppl 4:46-52. Review.

6.

Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

Hunziker ME, Suehs BT, Bettinger TL, Crismon ML.

Clin Ther. 2005 Aug;27(8):1126-43. Review.

PMID:
16199241
7.
8.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
9.

Continuation treatment of major depressive disorder: is there a case for duloxetine?

Norman TR, Olver JS.

Drug Des Devel Ther. 2010 Feb 18;4:19-31. Review.

10.

Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.

Rabasseda X.

Drugs Today (Barc). 2004 Sep;40(9):773-90. Review.

PMID:
15538550
11.

Review of duloxetine in the management of diabetic peripheral neuropathic pain.

Smith T, Nicholson RA.

Vasc Health Risk Manag. 2007;3(6):833-44. Review.

Supplemental Content

Support Center